Avalo Therapeutics Inc (NASDAQ:AVTX) Is Currently -390.18% Below Its 52-Week High, But Downside Potential Could Surprise You.
In last trading session, Avalo Therapeutics Inc (NASDAQ:AVTX) saw 0.11 million shares changing hands with its beta currently measuring 0.91. Company’s recent per share price